source
- Craif raises $33M to expand its urine-based pancreatic cancer testAI biopharma Craif announced a $33 million Series D financing, bringing its total capital raised to $88 million. The funding will be used to scale research on its urine-based microRNA test, miSign…
- J&J MedTech secures FDA 510(k) clearance for Monarch Quest 3 bronchoscopy software updateJohnson & Johnson MedTech announced that its Monarch bronchoscopy robot has received FDA 510(k) clearance for the latest software version, Monarch Quest 3. This marks the fourth major software laun…